FAQ & Customer Notifications

A prescription is required to get a LucentAD test. Please contact your healthcare provider to discuss whether the LucentAD test is appropriate for you.

A healthcare worker will collect a small amount of blood from a vein in your forearm using a standard collection vial. Your blood test sample will be sent to Quanterix Corporation (Quanterix, provider of the LucentAD test) for laboratory analysis.

The LucentAD test is new and is not currently covered by private insurance payers, Medicare or Medicaid. Patients are responsible for paying for the test out-of-pocket. Quanterix is currently working to establish reimbursement for the LucentAD test.

You will receive a bill from your provider.

Lucent Diagnostics will send a lab report with the test results to your healthcare provider within ten business days of receipt of the blood sample. You can request a copy of your lab report from your healthcare provider.

The LucentAD test lab report includes your pTau level which will be referenced against the LucentAD clinical cutoff for likelihood of Alzheimer’s pathology test. Your healthcare provider will discuss your report with you, answer any questions, and discuss next steps of your care.

Alzheimer’s disease is the most common cause of dementia, a general term for memory loss and other cognitive issues serious enough to interfere with daily life. Alzheimer’s disease accounts for 60-80% of dementia cases. For more information and resources on Alzheimer’s disease, please visit Alzheimer’s Association – What is Alzheimer’s.